Secondary hypertension - endocrine screening
2ndary HTN · Endocrine
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Structured evaluation for a hormonal cause of hypertension, prompted by resistant, early-onset, or hypokalaemic hypertension. Identifying a curable endocrine cause can resolve or markedly improve blood pressure.
Red flags
- Hypertensive emergency with end-organ damage
- Paroxysmal headache/palpitations/sweating (phaeochromocytoma)
- Severe spontaneous hypokalaemia
- Rapidly progressive or malignant hypertension
- Young patient with severe hypertension and a family history
Assessment
Differential diagnosis
- Primary aldosteronism
- Phaeochromocytoma/paraganglioma
- Cushing syndrome
- Thyroid dysfunction
- Renal artery stenosis/renal parenchymal disease
- Obstructive sleep apnoea
- Drug-induced hypertension
Investigations
- Aldosterone-to-renin ratio (ideally off interfering drugs)
- Plasma/24h urinary metanephrines
- 1 mg overnight dexamethasone suppression test if Cushing suspected
- TSH, U&E (hypokalaemia) and renal imaging as indicated
- Confirmatory tests (saline suppression, adrenal imaging, adrenal vein sampling) per positive screen
Management
- Identify who to screen: resistant, early-onset (<40), severe, or hypokalaemic hypertension and incidentaloma
- Review drugs and lifestyle factors raising blood pressure
- Screen for primary aldosteronism with aldosterone-to-renin ratio in appropriate patients
- Screen for phaeochromocytoma with metanephrines if paroxysmal symptoms or incidentaloma
- Screen for Cushing if clinical features present
- Check thyroid function and consider renovascular and sleep apnoea assessment
- Confirm positive screens with definitive testing before intervention
- Localise with adrenal imaging and, for aldosteronism, adrenal vein sampling if surgery considered
- Treat the specific cause (surgery, mineralocorticoid antagonist, etc.)
- Continue general antihypertensive and cardiovascular risk management
Drugs & doses
Spironolactone 25-50 mg or eplerenone PO for confirmed primary aldosteronism (medical arm)
Alpha-blockade before phaeochromocytoma surgery
Standard antihypertensives (avoiding those that invalidate ARR where feasible)
Cause-specific therapy after confirmation
Disposition
Investigate via primary care/hypertension clinic with endocrinology referral for confirmatory testing; refer surgically correctable causes to specialist centres.
Complications & pitfalls
- Accelerated cardiovascular and renal damage if untreated
- Phaeochromocytoma crisis
- Missed curable cause with lifelong unnecessary polypharmacy
- Electrolyte disturbances
Exam pearls
- Primary aldosteronism is far commoner than historically thought; screen all resistant/hypokalaemic hypertension
- Many antihypertensives distort the aldosterone-to-renin ratio, so interpret carefully or adjust drugs
- Normal potassium does not exclude primary aldosteronism
- Always exclude phaeochromocytoma before adrenal surgery for any cause
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.